The report highlights early metabolic studies, selected clinical trials, and certain double-blind placebo-controlled investigations that examined markers such as: blood sugar regulation insulin sensitivity cholesterol levels impaired glucose tolerance adipose tissue activity fat release and lipolytic activity While these studies generated interest in AOD-9604 as a potential anti-obesity drug candidate , the report stresses that no authority recognizes it as an active treatment for obesity, weight loss, or human use and emphasizes that it remains designated strictly for research use
Mechanisms of Ageing and Development, 89 (3), 125-154
It may help alleviate conditions, such as arthritis, gastrointestinal disorders, and musculoskeletal injuries
That ensures the greatest benefit
Potential side effects include nasal discomfort, headache, nausea, runny nose, feeling weak, infection, inflamed or swollen tongue, burning or prickling sensation in the arms or legs, and stuffy nose
